Now Enrolling...

The ChoICE Breast Cancer Cryoablation Clinical Trial


Help Spread The Word



Dr. Holmes is now considering potential participants for the ChoICE Trial, a
multicenter study evaluating cryoablation for the treatment of early-stage breast cancer in women age 70 and older. The trial will begin enrolling participants in August 2026.


The ChoICE Trial is a follow-up study to the landmark ICE3 Trial, which contributed to FDA approval of a breast cancer cryoablation device for selected patients with early-stage breast cancer. As a condition of FDA approval, IceCure Medical, the study sponsor, is conducting this 400-patient study.


The ChoICE Trial is open to women who meet the following criteria:


-70 years of age or older

-Diagnosis of invasive ductal carcinoma by core needle biopsy

-A single site of disease

-Tumor size equal to or less than 1.5 cm in greatest diameter as measured by breast ultrasound

-Estrogen receptor positive (ER+)

-Progesterone receptor positive (PR+)

-HER2 negative (HER2-)

-Favorable (low-risk) tumor biology (Ki-67 ,15%) or genomic testing showing low risk of recurrence (e.g., Mammaprint, Oncotype DX)


Cryoablation is performed under local anesthesia using ultrasound and a needle-like cryoprobe that freezes and kills the cancer with liquid nitrogen.

The ChoICE trial
requires a 5-year course of anti-estrogen after cryoablation. Radiation therapy and sentinel node biopsy are optional.

A pioneer in breast cancer cryoablation with
more than 20 years of cryoablation clinical and research experience, Dr. Holmes is pleased to launch the first west coast study site of this multicenter trial.


The cost of the cryoablation procedure will be billed to insurance or Medicare. However, if insurance does not cover the procedure, the cryoablation treatment will be provided at no cost to the patient. California residency is not required.


In addition to the ChoICE Trial, Dr. Holmes will continue to offer cryoablation to suitable patients outside of the trial.


For more information about ChoICE Trial eligibility or breast cancer cryoablation, contact us at info@cryoablation.com or www.cryoablation.com.


A New Podcast Interview



Dr. Holmes was interviewed on a podcast produced by the Annals of Surgical Oncology about the FROST Cryoablation Trial.


SurgOnc Today®: ASO Article Series: "Cryoablation: A Minimally Invasive Alternative for Early-Stage Breast Cancer: 6-Year Outcomes of the FROST Clinical Trial"


In this new episode of Speaking of SurgOnc, Dr. Rick Greene & Dr. Dennis Holmes discuss the article: "Cryoablation: A Minimally Invasive Alternative for Early-Stage Breast Cancer: 6-Year Outcomes of the FROST Clinical Trial" from the April 2026 issue of the Annals of Surgical Oncology.

You can listen to the podcast by selecting this link.



Review of Breast Cancer Cryoablation Clinical Trials



I
n preparation for several upcoming presentations, I created this timeline highlighting the key clinical studies that have shaped breast cancer cryoablation, including those in which I was an investigator. Although much work remains before cryoablation becomes widely available and routinely reimbursed by insurers, this timeline illustrates how far the field has come—and where it is heading in the immediate future.


The journey began with Fukuma’s pioneering, unpublished Kameda experience in Japan, in which patients received cryoablation, radiation therapy, and anti-estrogen therapy. It continued with the ICE3 and FROST trials, which evaluated cryoablation without surgery and, in selected cohorts, without radiotherapy or sentinel lymph node surgery. The available evidence now suggests that appropriately selected women undergoing breast cryoablation can expect local recurrence rates within the range reported for similar women treated with lumpectomy—while benefiting from faster recovery, better quality of life, greater physical and sexual well-being, and greater satisfaction with breast appearance.


 
 

Dennis R. Holmes, MD, FACS

Breast Cancer Surgeon and Researcher


1-818-630-8680


Sam and Grace Carvajal Comprehensive Breast Cancer

Adventist Health Glendale

1505 Wilson Terrace, Suite 370

Glendale, CA 91206



www.cryoablation.com